Skip to search formSkip to main contentSkip to account menu

CancerVax

Known as: C-VAX 
CancerVax is an allogenic polyvalent vaccine composed of irradiated but viable cells from three melanoma cell lines and Bacille Calmette-Guerin (BCG… 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

polyvalent melanoma cell vaccine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Amgen swallows Micromet to BiTE into ALL market
volume 30 number 4 APrIl 2012 nature biotechnology “It’s pioneering technology based on a simple, elegant concept,” enthuses… 
2006
2006
Reverse mergers attract top-tier biotechs in sluggish IPO market
Essentially the acquisition of a public company shell by a privately-held company in order access public capital, the reverse… 
2005
2005
Expediting Oncology Drug Approvals: The Public Backlash Against the FDA and Opportunities to Reform
The FDA has made great strides over the past twenty years in loosening drug approval regulations to speed important, life-saving… 
2004
2004
Technology evaluation: Canvaxin, John Wayne Cancer Institute/CancerVax.
  • S. Motl
  • Current opinion in molecular therapeutics (Print)
  • 2004
  • Corpus ID: 20197131
CancerVax and the John Wayne Cancer Institute are co-developing Biotechnology Tumor antigen Canvaxin, a vaccine containing over… 
2003
2003
Humoral immune response to a therapeutic polyvalent cancer vaccine after complete resection of thick primary melanoma and sentinel lymphadenectomy.
PURPOSE A therapeutic polyvalent cancer vaccine (Canvaxin vaccine; CancerVax Corp, Carlsbad, CA) induces antibodies to a… 
2002
2002
Active immunotherapy by reinduction with a polyvalent allogeneic cell vaccine correlates with improved survival in recurrent metastatic melanoma
BackgroundWe have observed prolonged survival in patients undergoing vaccine reinduction after resection of recurrent metastatic… 
Review
2002
Review
2002
Cancer vaccines, a critical review--Part I.
Cancer vaccines are more properly referred to as 'active specific immunotherapy', and are used to treat cancers rather than to… 
2001
2001
A vaccine for colorectral cancer.
Review
1999
Review
1999
Surgery for Melanoma Metastatic to the Gastrointestinal Tract
The retrospective review from the Memorial SloanKettering Cancer Center by Agrawal et al. published in this issue of Annals of… 
1998
1998
A melanoma vaccine that works? Evidence for a phase III national trial
CancerVax, a polyvalent melanoma cell containing at least 15 antigens that have been identified as relatively melanoma-specific… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)